TW432040B - Phenoxyacetic acid derivative having β3-adrenoceptor stimulating activities and pharmaceutical composition comprising the same - Google Patents

Phenoxyacetic acid derivative having β3-adrenoceptor stimulating activities and pharmaceutical composition comprising the same Download PDF

Info

Publication number
TW432040B
TW432040B TW088111496A TW88111496A TW432040B TW 432040 B TW432040 B TW 432040B TW 088111496 A TW088111496 A TW 088111496A TW 88111496 A TW88111496 A TW 88111496A TW 432040 B TW432040 B TW 432040B
Authority
TW
Taiwan
Prior art keywords
group
lower alkyl
carbon atom
conductive ball
mono
Prior art date
Application number
TW088111496A
Other languages
English (en)
Inventor
Nobuyuki Tanaka
Tetsuro Tamai
Harunobu Mukaiyama
Akihito Hirabayashi
Hideyuki Muranaka
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of TW432040B publication Critical patent/TW432040B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Maintenance And Inspection Apparatuses For Elevators (AREA)

Description

2040 五、新型說明 【新型所屬之技術領域】 _本創作係提供-種可調整之多功能地震感測裝置，可袭 設於大樓電梯機房或任何需要地震感測的地方，尤指技 術上提供—種使用者可自行調整分級並且可多方向_ 震動’不會因輕微震動就產生誤動作現象之地震感測裝 置’特別的是裝置内之電梯自動到樓模組適用於市面上 各廠牌之新型或老舊電梯系統。 【先前技術】 _]大地震常對人類生活所造成極切傷害尤其是都市的 人口密集區但目前所採用的地震感測裝置多屬於精密 合易發生故障的電子式精密設備，其價格及維護 費用相當高’導致政府機關或民間機構無能力增多配置 或使用低廉的市售地震感測器元件，由於太過靈敏且無 法調整分級’造成誤動作現象頻傳；尤其是台灣大樓林 立夕數大樓並未配置地震自動到樓系統，以致地震發 生時電梯轉致人員無法脫困之情料常發生。而市售 的地震感測裝置通常會利㈣珠開關或水銀開關來設計 ’但因其動作方向固^ ’無法俄測出其他方向的震動， 故使用範圍並不廣泛；而針對上述習知結構所存在之問 題點’開發-種實雜與廣泛性兼具的多功能地震感測 裝置乃當務之急。 有鑑於此，創作人本於從事機械設計多年實務經驗，針 對上述可調整之多魏地震感測裝置詳加設計，終設計 出兼具實用性與廣泛性之本創作。 l〇l2〇354(f·單編號 A0101 第3頁/共13頁 1013127727-0 M432040 101年04月05日孩正替換頁 【新型内容】 [0003]本創作係為一種可調整之多功能地震感測裝置，為使貴 審查委員能對本創作之特徵、目的及功能有更進一步的 認知與瞭解，茲配合圖式詳細說明如下：請參照參閱第 二圖所示，其主要結構包括有：電源模組（9)、遙控模組 (10)、電梯自動到樓模組（11)、底板（12)、圓錐筒 (15)、耳孔（16)、耳孔螺絲（17)、導線孔（18)、導線 (19)、導電片（20)、水平導電球（21)、μ型固定架（22) 、水平調整螺絲（23) '垂直導電球（25) '圓錐凹槽（26) 、垂直調整螺絲（27)、感應棒（29)、延伸彈簧（30)、固 痛 定筒（31)、固定筒圓孔（32)、L型固定架（33)及固定架 螺絲（34)。電源模組（9)、遙控模組（1 〇)及電梯自動到 樓模組（11)固定於底板（12)，導電片（20)置於圓錐筒 (15)内側’耳孔（16)連接圓錐筒（15)並用耳孔螺絲 (17)固定於底板（丨2)，導線（19)前端穿過導線孔（18) 後連接水平導電球（21) ’導線（19)末端則連接水平調整 螺絲（23)並固定於Μ型固定架（22);固定筒（31)置於L型 固定架（33)並用固定架螺絲（34)固定於底板（12)，延伸 ® 彈簧（30)連接垂直導電球（25)並置於固定筒（31)内，延 伸彈簧（30)另一端各自連接μ型固定架（22)及底板（12) ’感應棒（29)後端連接垂直調整螺絲（27)並固定於L型 固定架（33) ’感應棒（29)前端則通過固定筒圓孔（32)置 於垂直導電球（25)的圓錐凹槽（26)内。參閱第二圖所示 ，水平調整螺絲（23)可以調整水平導電球（21)的高度， 而垂直調整螺絲（27)可調整感應棒（29)在垂直導電球 (25)之圓錐凹槽（26)内的距離。 1013127727-0 10120354(^單編號Α〇101 第4頁/共13頁 [0004] M432040 實施方幻 供—種可調整之多功能地震感_，可裝 :=樓電梯機房或任何需要地震感測的地方，尤指技 :雪0供—種使用者可以自行調整分級並且可多方向偵 動’不會因輕微震動就產生誤動作現象之地震感測 :。參閱第四圖所示，當因地震產生地殼一定程度的 平或垂直震動時，水平導電球（21)和垂直導電球（25) 内的圓錐凹槽（26)會分別接觸到圓錐筒（⑸内的導電片 % 感應棒（29) ’此時產生一偵測訊號傳至遙控模組 )及電梯自動到樓換組⑴），遙控模組（⑴藉此控制 4閱第一圖所示之警示燈⑸、發射器⑻、蜂鳴器⑻ 及時間紀錄器（35)，而電梯自動到樓模組⑴）將輸出信 旒接至參閱第三圖所示之端子排（13)，主要用以提供連 接電梯系統；如此動作便構成一種多方向地震感測裝置 ，可有效解決習用地震感測器動作方向固定及太過靈敏 且無法調整分級而造成誤動作頻傳的現象。由上述可知 ，本創作之可調❹魏地震感縣1確為#界首見， 其創新設計符合㈣專狀進步性要件，其安全性及適 用性得以充分滿足業界之_目的，亦符合產業利用性 。另業界熟悉此項技術之人士當可在不脫離本創作精神 與原則下對本_進行變更輕改，惟錢更或修改皆 應涵蓋於申請專利範圍界定之範疇内。综上所述，本創 作係提供一種使用者可自行調整分級並且可多方向偵測 震動之地震感測裝置，特別的是裝置内之電梯自動到樓 模組適用於市面上各廠牌之新型或老舊電梯系統，其組 合結構並未見於同類產品，亦未曾公開於申請前，誠已 l〇120354(f·單編號Α0101 第5頁/共13頁 1013127727-0 M432040 101年.04月05日修正替換頁 符合專利法之規定，爰依法提出申請，懇請詳加細審， 並准予專利。 【圖式簡單說明】 [0005] 第一圖：本創作之面板示意圖 第二圖：本創作之平面透視圖 第三圖：本創作之平面配置圖 第四圖：本創作之動作狀態圖 【主要元件符號說明】 [0006] ( 1 )…面板 (2 )…面板螺絲 (3) …指示燈組 (4) …控制開關組 (5) …警示燈 (6) …蜂鳴器 (7) …水平儀 (8) …遙控器發射孔 (9) …電源模組 (10) …遙控模組 (11) …電梯自動到樓模組 (12 )…底板 (13) …端子排 (14) …端子排螺絲 (15) …圓錐筒 (16) …圓錐筒耳孔 (17) …耳孔螺絲 1〇12〇354(Ρ编號 A0101 第6頁/共13頁 1013127727-0 M432040 101年.04月05日梭正替換頁 (18) …導線孔 (19) …導線 (20) …導電片 (21) …水平導電球 (22) ···Μ型固定架 (23) …水平調整螺絲 (24) …水平調整螺帽 (25) …垂直導電球 (26) …圓錐凹槽 • • (27) …垂直調整螺絲 (28) …垂直調整螺帽 (29) …感應棒 (30) …延伸彈簧 (31) …固定筒 (32) …固定筒圓孔 (33) *"L型固定架 (34) …固定架螺絲 (35) …時間紀錄器 1012觀(P 職 A〇101 第7頁/共13頁 1013127727-0 Μ432β祕號：1Q腦540 智專收字第：1013127727-靳形鮮豐日 OTD版本：I·0-2 ※記號 部分請勿填寫 ※申請案號：101203540 ※申請a : (ο I . ^ ^ P C分類： (s\〇 I \/ 新型名稱： 可調整多功能地震感測裝置 中文新型摘要： \丨\、 (2〇〇6 ,01) 公告本 -種可調整之多功能地震感測裝置，可裝設於大樓電梯機房 φ 或任何需要地震感測的地方。裝置主要設有圓錐筒、導線孔 、導線、導電片、水平導電球、水平調整料、垂直導電球 、垂直調整螺絲、感應棒、延伸彈簧、固定筒及電梯自動到 樓模組；導線前端連接水平導電球置於圓錐筒内，導線後端 則穿過導線孔nm水平調整_，導電片置於圓錐筒内壁 ’垂直導電球連接延伸彈簧並置於©定筒内，感應棒前端連 接垂直調整縣’感應棒後制置於垂直導電球之圓錐四槽 中心處·>當地震出現—定程度的水平或垂直位移時水平導 _ 電球及垂直導電球會因搖晃*分別碰觸圓錐筒内之導電片及 ®錐凹槽内壁’此時送出錢至電梯自動到樓模組，電梯自 卜 動到樓模組會即時控制電梯停至最近樓層並開門讓人員逃出 ，如此便可有效保障人貞搭乘電梯的安全，特別的是不論任 何廠牌之新型或老舊電梯系統皆適用。 三、英文新型摘要：
J〇i2(?354(^單編號 A010J 第J頁/共〗3頁 1013127727-0 M432040 101年.04月05日核正替換頁 六、申請專利範圍： 1 . 一種可調整多功能地震感測裝置，裝置主要設有遙控模組 、電梯自動到樓模組、底板、圓錐筒、導線孔、導線、導 電片、水平導電球、Μ型固定架、水平調整螺絲、垂直導 電球、圓錐凹槽、垂直調整螺絲、感應棒、延伸彈簧、固 定筒、及L型固定架；圓錐筒、Μ型固定架、L型固定架、 遙控模組及電梯自動到樓模組皆固定於底板，圓錐筒内側 貼上導電片，導線前端穿過導線孔後連接水平導電球，導 線末端則連接水平調整螺絲並固定於Μ型固定架，固定筒
I 置於L型固定架，延伸彈簧連接垂直導電球並置於固定筒 内，延伸彈簧另一端分別固定於Μ型固定架及底板，感應 棒後端連接垂直調整螺絲並固定於L型固定架，感應棒 (29)前端則置於垂直導電球（25)的圓錐凹槽（26)内，當 水平導電球及垂直導電球之圓錐凹槽因震動分別接觸到導 電片或感應棒，此時產生偵測訊號傳至遙控模組及電梯自 動到樓模組，如此動作便構成一種可調整及具多方向偵測 能力的地震感測裝置。 < 2 .如申請專利範圍第1項所述之可調整多功能地震感測裝置 ，其中圓錐筒包含導線、導線孔、導電片、水平導電球及 _ 水平調整螺絲，水平調整螺絲用於調整水平導電球與底板 間的距離。 3 .如申請專利範圍第1項所述之可調整多功能地震感測裝置 ，其中垂直導電球包含圓錐凹槽、延伸彈簧、感應棒及垂 直調整螺絲，垂直調整螺絲用於調整感應棒與圓錐凹槽間 的距離。 4 .如申請專利範圍第1項所述之可調整多功能地震感測裝置 10120354(^單編號删1 第 8 頁 / 共 13 頁 1013127727-0 M432040 ，其中電梯自動到樓模組包含遙控模組 排，端子排主要用於連接電梯***線路 101年.04月的日按正替换頁 電源模組及端子
1012035#^'^^ A〇101 第9頁/共13頁 1013127727-0
TW088111496A 1998-07-08 1999-07-07 Phenoxyacetic acid derivative having β3-adrenoceptor stimulating activities and pharmaceutical composition comprising the same TW432040B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22850198 1998-07-08

Publications (1)

Publication Number Publication Date
TW432040B true TW432040B (en) 2001-05-01

Family

ID=16877446

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088111496A TW432040B (en) 1998-07-08 1999-07-07 Phenoxyacetic acid derivative having β3-adrenoceptor stimulating activities and pharmaceutical composition comprising the same

Country Status (28)

Country Link
US (1) US6538152B1 (zh)
EP (1) EP1095932B1 (zh)
JP (2) JP4132010B2 (zh)
KR (1) KR100516277B1 (zh)
CN (1) CN1242983C (zh)
AR (1) AR029600A1 (zh)
AT (1) ATE267161T1 (zh)
AU (1) AU771200B2 (zh)
BR (1) BR9911871B1 (zh)
CA (1) CA2336853C (zh)
CO (1) CO5070574A1 (zh)
CZ (1) CZ302727B6 (zh)
DE (1) DE69917459T2 (zh)
DK (1) DK1095932T3 (zh)
ES (1) ES2221390T3 (zh)
HK (1) HK1039480A1 (zh)
HU (1) HUP0103008A3 (zh)
IL (1) IL140498A (zh)
MY (1) MY126489A (zh)
NO (1) NO327770B1 (zh)
NZ (1) NZ509203A (zh)
PE (1) PE20000758A1 (zh)
PL (1) PL197453B1 (zh)
PT (1) PT1095932E (zh)
SA (1) SA99200411B1 (zh)
TW (1) TW432040B (zh)
WO (1) WO2000002846A1 (zh)
ZA (1) ZA200100135B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ585000A0 (en) * 2000-02-28 2000-03-16 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
JP4157036B2 (ja) * 2001-09-13 2008-09-24 キッセイ薬品工業株式会社 ヒドロキシノルエフェドリン誘導体塩酸塩の結晶
UA79498C2 (en) * 2002-09-05 2007-06-25 Kissei Pharmaceutical Intermediates for preparation of phenoxy-acetic derivates and processes of their preparation
ZA200503510B (en) 2002-11-07 2006-12-27 Yamanouchi Pharma Co Ltd Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
JP4602969B2 (ja) * 2003-05-05 2010-12-22 キッセイ薬品工業株式会社 過活動膀胱を治療するためのフェノキシ酢酸誘導体の使用
DE10351271A1 (de) * 2003-10-31 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung der Stressinkontinenz und/oder Mischinkontinenz
BRPI0416157A (pt) * 2003-11-03 2007-01-09 Boehringer Ingelheim Int composição farmacêutica contendo um agonista de adrenoceptor beta-3 e um antagonista alfa e/ou um inibidor de 5-alfa redutase
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
DE10356112A1 (de) * 2003-11-27 2005-06-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem in den Prostglandinstoffwechsel eingreifendem Wirkstoff
JP4808613B2 (ja) * 2004-03-24 2011-11-02 キッセイ薬品工業株式会社 頻尿または尿失禁の予防または治療用医薬
WO2005092321A1 (ja) * 2004-03-24 2005-10-06 Kissei Pharmaceutical Co., Ltd. 頻尿または尿失禁の予防または治療用医薬組成物
JP2008516909A (ja) * 2004-10-18 2008-05-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 前立腺及び下部泌尿生殖路の病気を治療するためのβ−３アゴニストの使用
DE102004050952A1 (de) * 2004-10-18 2006-04-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind
US20090247781A1 (en) 2004-10-26 2009-10-01 Kissei Pharmaceutical Co., Ltd. Synthesis of phenoxyacetic acid derivatives
TWI356699B (en) 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
LT5282B (lt) 2005-02-28 2005-10-25 Kissei Pharmaceutical Co., Ltd. Tarpiniai junginiai fenoksiacto rūgšties darinių gamyboje ir jų panaudojimo būdas
WO2006123517A1 (ja) * 2005-04-26 2006-11-23 Kissei Pharmaceutical Co., Ltd. ヒドロキシノルエフェドリン誘導体塩酸塩の結晶多形
EP1878718A4 (en) * 2005-04-26 2010-07-28 Kissei Pharmaceutical CRYSTAL OF A HYDROXYNOREPHEDRINE DERIVATIVY HYDROCHLORIDE 1/4 HYDRATE
CA2619445A1 (en) * 2005-08-29 2007-03-08 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
EP1769792A1 (de) 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
JPWO2007083640A1 (ja) * 2006-01-18 2009-06-11 杏林製薬株式会社 頻尿及び尿失禁の予防又は治療剤
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6401871A (zh) 1964-02-27 1965-08-30
ATE1994T1 (de) * 1979-06-16 1982-12-15 Beecham Group Plc Aethanamin-derivate, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
WO1998013333A1 (fr) 1996-09-26 1998-04-02 Kissei Pharmaceutical Co., Ltd. Derives de 2-amino-1-(4-hydroxy-2-methylphenyl)propanol
ID24062A (id) 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing

Also Published As

Publication number Publication date
IL140498A0 (en) 2002-02-10
US6538152B1 (en) 2003-03-25
ATE267161T1 (de) 2004-06-15
AU771200B2 (en) 2004-03-18
CZ200173A3 (cs) 2002-01-16
AU4397399A (en) 2000-02-01
CN1242983C (zh) 2006-02-22
ZA200100135B (en) 2001-12-10
CA2336853A1 (en) 2000-01-20
PL345730A1 (en) 2002-01-02
EP1095932A4 (en) 2002-10-16
KR20010071772A (ko) 2001-07-31
PT1095932E (pt) 2004-09-30
JP4132010B2 (ja) 2008-08-13
IL140498A (en) 2004-06-20
EP1095932A1 (en) 2001-05-02
NO20010078D0 (no) 2001-01-05
BR9911871B1 (pt) 2010-10-19
NZ509203A (en) 2003-03-28
JP4871321B2 (ja) 2012-02-08
KR100516277B1 (ko) 2005-09-21
BR9911871A (pt) 2001-03-27
CO5070574A1 (es) 2001-08-28
DE69917459D1 (de) 2004-06-24
NO327770B1 (no) 2009-09-21
NO20010078L (no) 2001-03-08
ES2221390T3 (es) 2004-12-16
CZ302727B6 (cs) 2011-09-29
EP1095932B1 (en) 2004-05-19
AR029600A1 (es) 2003-07-10
CA2336853C (en) 2009-03-10
WO2000002846A1 (en) 2000-01-20
DK1095932T3 (da) 2004-09-20
HUP0103008A3 (en) 2002-12-28
HK1039480A1 (en) 2002-04-26
SA99200411B1 (ar) 2006-09-09
JP2008273965A (ja) 2008-11-13
DE69917459T2 (de) 2005-05-12
HUP0103008A2 (hu) 2001-12-28
MY126489A (en) 2006-10-31
PE20000758A1 (es) 2000-09-04
CN1308603A (zh) 2001-08-15
PL197453B1 (pl) 2008-04-30

Similar Documents

Publication Publication Date Title
TW432040B (en) Phenoxyacetic acid derivative having β3-adrenoceptor stimulating activities and pharmaceutical composition comprising the same
Park et al. Effects of air purifiers on patients with allergic rhinitis: a multicenter, randomized, double-blind, and placebo-controlled study
CN209326710U (zh) 一种无线温湿度传感器
CN211742314U (zh) 一种英语听力训练装置
CN206543280U (zh) 一种带红外装置库存管理的无线智能药箱
CN105278479A (zh) 基于物联网的液晶显示屏控制***
CN201429948Y (zh) 一种卫生间指示装置
CN209297447U (zh) 带有图书消毒功能的可移动式图书自助借还装置
CN214049834U (zh) 一种抗疫专用键盘鼠标消毒盒
CN207626792U (zh) 一种工商管理专用讲桌
CN209965650U (zh) 一种多功能教学课桌
CN205281414U (zh) 一种翻转式键盘鼠标消毒装置
CN205778311U (zh) 一种防盗门
CN209281646U (zh) 一种应用于物联网教学的多功能教具
CN215296448U (zh) 一种用于室内环境噪音检测的装置
CN220251894U (zh) 一种室内环境检测用空气质量检测设备
CN212061714U (zh) 一种吸附式桌牌会议发言终端装置
CN216258665U (zh) 一种老年痴呆护理用记忆力训练装置
TWI850105B (zh) 防跌病床系統
CN211529322U (zh) 一种大数据实验综合教学***装置
CN202694745U (zh) 悬浮互动玻璃
CN214623874U (zh) 一种心内科患者用呼救装置
CN215532475U (zh) 一种校园教育用网络设备
CN108568053A (zh) 一种防护性极强的杠铃式卧推装置
CN219126319U (zh) 一种婴儿监护器

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent